REAL LIFE DATA FROM THE FIRST LINE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA: EXPERIENCE OF A THIRD LEVEL CENTER

被引:0
|
作者
Sanchez-Raga, J. M. [1 ]
Perez-Montana, A. [1 ]
Beltran, N. [1 ]
Ros, T. [1 ]
Boyeras, B. [1 ]
Martorell, C. [1 ]
Gutierrez, A. [1 ]
Sampol, A. [1 ]
机构
[1] Hosp Univ Son Espases, Palma De Mallorca, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PO-008
引用
收藏
页码:194 / 194
页数:1
相关论文
共 50 条
  • [31] Health-related quality of life of multiple myeloma patients from a Brazilian metropolis improves after first line of treatment
    Drummond, Paula
    Santos, Roberta M.
    Reis, Adriano M.
    Malta, Jessica
    Silveira, Livia
    Costa, Iwyson H.
    Marques, Barbara
    De Padua, Cristiane Aparecida A. Menezes
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 505 - 505
  • [32] Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Single-Center Real Life Experience
    Canto, Chiara
    Ranucci, Elena
    Pulini, Stefano
    Santoleri, Fiorenzo
    Morelli, Anna Maria
    Fioritoni, Francesca
    Falorio, Simona
    Torti, Lorenza
    Spadano, Antonio
    D'Aloisio, Marianna
    Di Ianni, Mauro
    Santarone, Stella
    Di Bartolomeo, Paolo
    BLOOD, 2018, 132
  • [33] DARATUMUMAB IN MONOTHERAPY AND COMBINATION AS TREATMENT IN RELAPSED / REFRACTORY MULTIPLE MYELOMA: EXPERIENCE OF A THIRD LEVEL HOSPITAL
    Auria Caballero, C.
    Gamarro Calvo, S.
    De Poo Rodriguez, M., V
    Martinez Fernandez, R.
    Sanchez Quinones, B.
    Dourdil Sahun, M., V
    Bonafonte Arruga, E.
    Alcacera Lopez, A.
    Palomera Bernal, L.
    HAEMATOLOGICA, 2018, 103 : 124 - 124
  • [34] TRIAL EFFICACY VS REAL WORLD EFFECTIVENESS IN FIRST LINE TREATMENT OF MULTIPLE MYELOMA
    Liwing, J.
    Heeg, B. M.
    Karstorp, S.
    Postma, M.
    Silvennoinen, R.
    Putkonen, M.
    Anttila, P.
    Remes, K.
    Abildgaard, N.
    Waage, A.
    Nahi, H.
    HAEMATOLOGICA, 2015, 100 : 512 - 513
  • [35] BORTEZOMIB MAINTENANCE TREATMENT IN PATIENTS WITH MULTIPLE MYELOMA-A SINGLE CENTER EXPERIENCE
    Micheva, I.
    Dimitrova, S.
    Rachev, R.
    Varbanov, H.
    Mehmed, M.
    Gerov, V.
    Antonov, A.
    Gercheva, L.
    HAEMATOLOGICA, 2016, 101 : 796 - 796
  • [36] MAINTENANCE TREATMENT WITH THALIDOMIDE AFTER A FIRST LINE WITH BORTEZOMIB IN PATIENTS DIAGNOSED WITH MULTIPLE MYELOMA NON-TRANSPLANT CANDIDATES. EXPERIENCE OF A SINGLE CENTER
    De Miguel Llorente, D.
    Perez Gil, A.
    Golbano Lopez, N.
    Guillen Garcia, H.
    Vazquez Ramo, A.
    Perez Ortega, A.
    Arbeteta Juanis, J.
    Subira Perez, D.
    Morales Sanz, M. D.
    Juarez Salcedo, L. M.
    Herrero Martin, S.
    HAEMATOLOGICA, 2018, 103 : 306 - 306
  • [37] Real-life analysis of the multiple myeloma patient's survival in a third-level hospital
    Lopez-Munoz, Nieves
    Iniguez Garcia, Rodrigo
    Alonso Fernandez, Rafael Alberto
    Sanchez-Pina, Jose M.
    Cuellar, Clara
    Jimenez Ubieto, Ana
    Calbacho, Maria
    Ayala, Rosa
    Liz Paciello, M.
    Martinez Sanchez, M. Pilar
    Vera Guerrero, Elena
    Hidalgo Soto, Marta
    Poza, Maria
    Zamanillo, Irene
    Martinez-Lopez, Joaquin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S116 - S116
  • [38] The addition of thalidomide in any line of treatment of multiple myeloma, improves overall survival: Single center experience in 246 patients
    Katodritou, Eirini
    Verrou, Evgenia
    Banti, Anastasia
    Gastari, Vassiliki
    Mihou, Dimitra
    Hadjiaggelidou, Christina
    Markala, Dimitra
    Lazaridou, Anna
    Terpos, Evangelos
    Zervas, Konstantinos
    BLOOD, 2007, 110 (11) : 277B - 277B
  • [39] MP VS MPT IN FIRST TO FOURTH LINE OF TREATMENT IN MULTIPLE MYELOMA PATIENTS
    Lund, J.
    Uttervall, K.
    Liwing, J.
    Aschan, J.
    Alici, E.
    Holmberg, E.
    Nahi, H.
    HAEMATOLOGICA, 2013, 98 : 326 - 326
  • [40] Real-World Treatment Patterns of Patients Initiating Third-Line Therapy in Relapsed or Refractory Multiple Myeloma in Europe
    Lehne, Moritz
    Kortuem, K. Martin
    Zamagni, Elena
    d'Estrube, Tim
    Shukla, Soham
    Zhuleku, Evi
    Ghiani, Marco
    Hanna, Maya
    Maywald, Ulf
    Wilke, Thomas
    Perera, Sue
    BLOOD, 2022, 140 : 12485 - 12486